← FDA DRUG APPROVALS

FDA ANDA · ANDA090963

GLYCOPYRROLATE

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA090963
TYPE
ANDA
ORIGINAL APPROVAL
2011-09-21
LATEST ACTION
2019-08-31
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

GLYCOPYRROLATEPrescription
GLYCOPYRROLATE 0.2MG/ML · INJECTABLE · INJECTION

Approval history

2019-08-31Labeling · Supplement 12 · standardAP
2011-09-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →